MAPT and Alzheimer disease: The National Institute on Aging—Alzheimer’s Association Research Framework now defines Alzheimer’s disease (AD) as a pathologic continuum, a process of cerebral amyloid-β (Aβ) and tau accumulation that begins when individuals are cognitively unimpaired1.